By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Single segment25.42M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States25.42M100.00%
US Stock MarketDetailed Quotes
Entrada Therapeutics (TRDA)
- 14.500
- +1.000+7.41%
Close May 1 15:59 ET
- 14.593
- +0.093+0.64%
Post 20:01 ET
562.90MMarket Cap-4.18P/E (TTM)
14.560High13.114Low323.34KVolume13.460Open13.500Prev Close4.61MTurnover1.32%Turnover RatioLossP/E (Static)38.82MShares14.56052wk High1.84P/B355.80MFloat Cap4.93052wk Low--Dividend TTM24.54MShs Float36.850Historical High--Div Yield TTM10.71%Range %4.930Historical Low14.256Avg Price1Lot Size
Entrada Therapeutics (TRDA) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm